Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

POKONZA

POTASSIUM CHLORIDE

Standard Dose
10MEQ
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview POKONZA is listed in Drugs@FDA under application 208019 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM CHLORIDE Form and strength FOR SOLUTION;ORAL - 10MEQ Sponsor GENUS Submission history Latest submission status date: 2020-03-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview POKONZA is listed in Drugs@FDA under application 208019 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient POTASSIUM CHLORIDE Form and strength FOR SOLUTION;ORAL - 10MEQ Sponsor GENUS Submission history Latest submission status date: 2020-03-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.